COST-EFFECTIVENESS ANALYSIS OF END-STAGE RENAL-DISEASE TREATMENTS

被引:68
作者
GARNER, TI
DARDIS, R
机构
[1] UNIV MARYLAND,DEPT TEXTILES & CONSUMER ECON,COLLEGE PK,MD 20742
[2] US BUR LABOR STAT,WASHINGTON,DC 20214
关键词
D O I
10.1097/00005650-198701000-00004
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
引用
收藏
页码:25 / 34
页数:10
相关论文
共 22 条
[1]  
BIRNBAUM H, 1978, COST CATASTROPHIC IL
[2]  
BRODY WH, 1975, DHEW7511701 SOC SEC
[3]   COST-BENEFIT ANALYSIS OF LONG-TERM HEMODIALYSIS FOR CHRONIC RENAL-FAILURE [J].
BUXTON, MJ ;
WEST, RR .
BRITISH MEDICAL JOURNAL, 1975, 2 (5967) :376-379
[5]   IMPLICATIONS FOR HEALTH-CARE POLICY - A SOCIAL AND DEMOGRAPHIC PROFILE OF HEMODIALYSIS-PATIENTS IN THE UNITED-STATES [J].
EVANS, RW ;
BLAGG, CR ;
BRYAN, FA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1981, 245 (05) :487-491
[6]  
EVANS RW, 1982, CASE MIX TREATMENT M, V14
[7]  
HELD PJ, 1979, FINANCIAL INCENTIVES
[8]  
KRAKAUER H, 1980, NIH802164 PUBL
[9]  
LESOURD DA, 1968, PHS PUBLICATION, V1941
[10]   A COST-EFFECTIVENESS ANALYSIS OF THE TREATMENT OF CHRONIC-RENAL-FAILURE [J].
LUDBROOK, A .
APPLIED ECONOMICS, 1981, 13 (03) :337-350